Principal Financial Group Inc Alkermes Plc. Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q4 2024

A detailed history of Principal Financial Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Principal Financial Group Inc holds 899,764 shares of ALKS stock, worth $31.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
899,764
Holding current value
$31.8 Million
% of portfolio
0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$25.7 - $31.46 $23.1 Million - $28.3 Million
899,764 New
899,764 $25.9 Million
Q3 2024

Oct 31, 2024
SELL
$23.01 - $28.55 $1.6 Million - $1.98 Million
-69,373 Reduced 7.32%
877,943 $24.6 Million
Q2 2024

Jul 29, 2024
SELL
$23.21 - $27.24 $724,964 - $850,841
-31,235 Reduced 3.19%
947,316 $22.8 Million
Q1 2024

Apr 29, 2024
BUY
$26.4 - $32.56 $1.03 Million - $1.27 Million
39,009 Added 4.15%
978,551 $26.5 Million
Q4 2023

Feb 07, 2024
BUY
$23.37 - $28.68 $20.2 Million - $24.8 Million
864,389 Added 1150.17%
939,542 $26.1 Million
Q3 2023

Nov 02, 2023
BUY
$27.17 - $31.97 $317,834 - $373,985
11,698 Added 18.44%
75,153 $2.11 Million
Q2 2023

Aug 07, 2023
SELL
$28.34 - $33.63 $209,375 - $248,458
-7,388 Reduced 10.43%
63,455 $1.99 Million
Q1 2023

May 09, 2023
SELL
$25.31 - $29.02 $227,815 - $261,209
-9,001 Reduced 11.27%
70,843 $2 Million
Q4 2022

Feb 09, 2023
BUY
$21.94 - $26.24 $120,648 - $144,293
5,499 Added 7.4%
79,844 $2.09 Million
Q3 2022

Nov 09, 2022
SELL
$22.0 - $31.87 $1.57 Million - $2.28 Million
-71,401 Reduced 48.99%
74,345 $1.66 Million
Q2 2022

Aug 10, 2022
SELL
$26.4 - $30.54 $1.5 Million - $1.73 Million
-56,759 Reduced 28.03%
145,746 $4.34 Million
Q1 2022

May 09, 2022
SELL
$23.07 - $27.99 $1.73 Million - $2.1 Million
-75,152 Reduced 27.07%
202,505 $5.33 Million
Q4 2021

Feb 09, 2022
BUY
$21.47 - $32.08 $52,859 - $78,980
2,462 Added 0.89%
277,657 $6.46 Million
Q3 2021

Nov 09, 2021
BUY
$23.37 - $32.13 $191,961 - $263,915
8,214 Added 3.08%
275,195 $8.49 Million
Q2 2021

Aug 10, 2021
BUY
$18.78 - $25.15 $124,567 - $166,819
6,633 Added 2.55%
266,981 $6.55 Million
Q1 2021

May 10, 2021
BUY
$18.21 - $23.2 $633,471 - $807,058
34,787 Added 15.42%
260,348 $4.86 Million
Q4 2020

Feb 08, 2021
SELL
$15.39 - $22.1 $846,757 - $1.22 Million
-55,020 Reduced 19.61%
225,561 $4.5 Million
Q3 2020

Nov 06, 2020
BUY
$16.16 - $20.66 $1.74 Million - $2.22 Million
107,627 Added 62.23%
280,581 $4.65 Million
Q2 2020

Aug 05, 2020
BUY
$13.31 - $19.41 $1.77 Million - $2.58 Million
132,733 Added 330.01%
172,954 $3.36 Million
Q1 2020

May 12, 2020
BUY
$13.06 - $21.24 $54,734 - $89,016
4,191 Added 11.63%
40,221 $580,000
Q4 2019

Feb 05, 2020
SELL
$17.29 - $21.74 $19,278 - $24,240
-1,115 Reduced 3.0%
36,030 $735,000
Q3 2019

Nov 13, 2019
BUY
$19.51 - $24.28 $936 - $1,165
48 Added 0.13%
37,145 $725,000
Q2 2019

Aug 12, 2019
SELL
$21.47 - $37.33 $103,700 - $180,303
-4,830 Reduced 11.52%
37,097 $836,000
Q1 2019

May 10, 2019
BUY
$28.4 - $36.49 $84,745 - $108,886
2,984 Added 7.66%
41,927 $1.53 Million
Q4 2018

Feb 14, 2019
SELL
$27.94 - $44.61 $189,768 - $302,991
-6,792 Reduced 14.85%
38,943 $1.15 Million
Q3 2018

Nov 14, 2018
BUY
$38.6 - $46.12 $69,480 - $83,016
1,800 Added 4.1%
45,735 $1.94 Million
Q2 2018

Aug 13, 2018
SELL
$40.56 - $51.36 $152,830 - $193,524
-3,768 Reduced 7.9%
43,935 $0
Q1 2018

May 14, 2018
BUY
$53.61 - $67.26 $121,373 - $152,276
2,264 Added 4.98%
47,703 $2.76 Million
Q4 2017

Feb 13, 2018
BUY
$47.69 - $55.39 $1.16 Million - $1.35 Million
24,413 Added 116.11%
45,439 $2.49 Million
Q3 2017

Nov 02, 2017
BUY
$49.16 - $54.45 $1.03 Million - $1.14 Million
21,026
21,026 $1.07 Million

Others Institutions Holding ALKS

# of Institutions
375
Shares Held
173M
Call Options Held
231K
Put Options Held
158K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email